A single arm, prospective multicenter phase II study FOLFIRINOX in patients with advanced and recurrent biliary tract cancer.

被引：3
|
作者：
Takahara, Naminatsu
Isayama, Hiroyuki
Nakai, Yousuke
Ioka, Tatsuya
Kanai, Masashi
Sasaki, Takashi
Furuse, Junji
Koike, Kazuhiko
机构：
[1] Univ Tokyo, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Hepatobiliary & Pancreat Oncol, Osaka, Japan
[4] Kyoto Univ Hosp, Kyoto, Japan
[5] JFCR, Canc Inst Hosp, Tokyo, Japan
[6] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.TPS514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS514
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
    Naminatsu Takahara
    Yousuke Nakai
    Hiroyuki Isayama
    Takashi Sasaki
    Yuji Morine
    Kazuo Watanabe
    Makoto Ueno
    Tatsuya Ioka
    Masashi Kanai
    Shunsuke Kondo
    Naohiro Okano
    Kazuhiko Koike
    Investigational New Drugs, 2023, 41 : 76 - 85
  • [2] A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Morine, Yuji
    Watanabe, Kazuo
    Ueno, Makoto
    Ioka, Tatsuya
    Kanai, Masashi
    Kondo, Shunsuke
    Okano, Naohiro
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (01) : 76 - 85
  • [3] Phase II Trial of FOLFIRINOX in Advanced Biliary Tract Cancer
    Bazarbashi, Shouki
    Aseafan, Mohamed
    Elshenawy, Mahmoud
    Alzahrani, Ahmed
    Aljubran, Ali H.
    Almugbel, Fahad
    Alzannan, Noura
    Elhassan, Tusneem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [4] Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II Study
    Lee, Yong-Pyo
    Oh, Sung Yong
    Kim, Kwang Min
    Go, Se-Il
    Kim, Jung Hoon
    Huh, Seok Jae
    Kang, Jung Hun
    Ji, Jun Ho
    CANCERS, 2022, 14 (08)
  • [5] Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer.
    Song, Eun-Kee
    Han, Hye-Suk
    Lee, Ki Hyeong
    Lee, Kyu Taek
    Bae, Sang Byung
    Kim, Han Jo
    Kim, Samyong
    Yun, Hwan Jung
    Cho, Sang Hoe
    Shim, Hyun-Jeong
    Yhim, Ho-Young
    Leo, Na-Ri
    Joon, So Yoon
    Yim, Chang-Yeoi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] A multicenter phase II study of gemcitabine (GEM) in patients with unresectable biliary tract cancer.
    Funakoshi, A
    Okusaka, T
    Ishii, H
    Yamao, K
    Ohkawa, S
    Saito, H
    Saito, S
    Tsuyuguchi, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 344S - 344S
  • [7] A multicenter, prospective observational study of chemotherapy in elderly patients with biliary tract cancer.
    Nakachi, Kohei
    Kobayashi, Satoshi
    Yamamoto, Kouji
    Ueno, Makoto
    Maruki, Yuta
    Ikezawa, Kenji
    Terashima, Takeshi
    Shimizu, Satoshi
    Oshima, Kotoe
    Tsuji, Kunihiro
    Nakase, Hiroshi
    Tsumura, Hidetaka
    Shibuki, Taro
    Ozaka, Masato
    Okano, Naohiro
    Okamura, Yukiyasu
    Umemoto, Kumiko
    Sato, Tatsunori
    Furuse, Junji
    Nagano, Hiroaki
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [8] A multicenter phase II trial of rucaparib in combination with nivolumab as maintenance therapy for patients with advanced biliary tract cancer.
    Sahai, Vaibhav
    Tran, Nguyen H.
    Griffith, Kent A.
    Zalupski, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] EXIBIT:: An international multicenter phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer.
    André, T.
    Reyes-Vidal, J. M.
    Fartoux, L.
    Ross, P.
    Leslie, M.
    Rosmorduc, O.
    Clemens, M. R.
    Louvet, C.
    Perez, N.
    Scheithauer, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 211S - 211S
  • [10] Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial
    Xu, Q.
    Chen, C.
    Huang, Z.
    Lin, Y.
    Liu, J.
    Li, L.
    Li, Z.
    Pan, J.
    Chen, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S752 - S753
12345